全文获取类型
收费全文 | 11741篇 |
免费 | 529篇 |
国内免费 | 138篇 |
专业分类
耳鼻咽喉 | 93篇 |
儿科学 | 194篇 |
妇产科学 | 94篇 |
基础医学 | 1347篇 |
口腔科学 | 321篇 |
临床医学 | 704篇 |
内科学 | 3215篇 |
皮肤病学 | 181篇 |
神经病学 | 855篇 |
特种医学 | 457篇 |
外科学 | 2460篇 |
综合类 | 51篇 |
预防医学 | 239篇 |
眼科学 | 137篇 |
药学 | 667篇 |
中国医学 | 17篇 |
肿瘤学 | 1376篇 |
出版年
2023年 | 91篇 |
2022年 | 145篇 |
2021年 | 314篇 |
2020年 | 186篇 |
2019年 | 214篇 |
2018年 | 277篇 |
2017年 | 209篇 |
2016年 | 275篇 |
2015年 | 285篇 |
2014年 | 403篇 |
2013年 | 482篇 |
2012年 | 737篇 |
2011年 | 833篇 |
2010年 | 460篇 |
2009年 | 394篇 |
2008年 | 696篇 |
2007年 | 720篇 |
2006年 | 718篇 |
2005年 | 784篇 |
2004年 | 759篇 |
2003年 | 711篇 |
2002年 | 686篇 |
2001年 | 200篇 |
2000年 | 167篇 |
1999年 | 214篇 |
1998年 | 184篇 |
1997年 | 130篇 |
1996年 | 132篇 |
1995年 | 87篇 |
1994年 | 83篇 |
1993年 | 77篇 |
1992年 | 90篇 |
1991年 | 71篇 |
1990年 | 64篇 |
1989年 | 79篇 |
1988年 | 56篇 |
1987年 | 47篇 |
1986年 | 51篇 |
1985年 | 38篇 |
1984年 | 30篇 |
1983年 | 29篇 |
1982年 | 12篇 |
1981年 | 16篇 |
1980年 | 13篇 |
1979年 | 19篇 |
1978年 | 19篇 |
1977年 | 14篇 |
1971年 | 12篇 |
1968年 | 11篇 |
1966年 | 11篇 |
排序方式: 共有10000条查询结果,搜索用时 656 毫秒
991.
Naoya Niwa Eiji Kikuchi Kazuhiro Matsumoto Takeo Kosaka Ryuichi Mizuno Mototsugu Oya 《Urologic oncology》2018,36(6):306.e1-306.e8
Purpose
It is still unknown whether switching the bacillus Calmette-Guérin (BCG) strain at the second induction course of BCG therapy has a therapeutic benefit in patients with tumor recurrence after the initial BCG therapy (BCG-relapsing tumor).Materials and methods
We retrospectively reviewed the clinicopathological features of 97 patients treated with a second induction course of BCG therapy between 1986 and 2014. Among the patients initially treated with BCG Tokyo-172, the second course was either BCG Tokyo-172 in 56 (57.8%) or BCG Connaught in 15 (15.5%). Among those who were initially treated with BCG Connaught, the corresponding numbers were 13 (13.4%) or 13 (13.4%), respectively. Twenty-eight (28.9%) patients were given a different BCG strain at the 2 BCG therapies (switching group), and 69 (71.1%) patients were given the same BCG strain (non-switching group).Result
The 5-year recurrence-free survival rate of the switching group was 64.7 ± 9.6%, which was not significantly different from that of the non-switching group (54.8 ± 6.9%, P = 0.427). Switching or not switching the BCG strain was not significantly associated with tumor recurrence after the second BCG therapy. The 5-year progression-free survival rate of the switching group was 95.4 ± 2.6%, which was also not significantly different from that of the non-switching group (96.0 ± 3.9%, P = 0.674). Patients treated with BCG Tokyo-172 to Tokyo-172 had significantly higher incidences of side effects during the second BCG therapy.Conclusions
The results of this study indicate that in patients with a BCG-relapsing tumor after the initial BCG therapy, the same BCG strain as that administered at the initial BCG therapy could be utilized effectively for the second BCG therapy. Patients treated with BCG Tokyo-172 for an initial tumor had a higher incidence of side effects during the second BCG therapy using the same strain. 相似文献992.
Suguru Oka Naoko Inoshita Yuji Miura Ryosuke Oki Yu Miyama Shoichi Nagamoto Kohei Ogawa Kazushige Sakaguchi Chihiro Kondoh Kazuhiro Kurosawa Shinji Urakami Toshimi Takano Toshikazu Okaneya 《Urologic oncology》2018,36(8):365.e9-365.e14
Objectives
Renal cell carcinoma (RCC) is characterized by a propensity for extension into the renal vein and inferior vena cava (IVC) and is associated with poor prognosis. BAP1 mutation, which occurs in about 15% of patients with clear cell RCC (ccRCC), also predicts poor prognosis. The aim of this study was to elucidate the association between BAP1 protein expression and clinicopathological outcomes in patients with nonmetastatic ccRCC with an IVC tumor thrombus (IVCTT).Material and methods
Thirty-five patients with nonmetastatic ccRCC with an IVCTT who underwent radical nephrectomy and tumor thrombectomy at our institution from 1999 to 2010 were retrospectively evaluated. Immunohistochemical (IHC) analyses were performed for the expression of BAP1 protein, and the associations between the expression of BAP1 and clinical outcomes were assessed. Survival analyses were performed using the Kaplan-Meier method and log-rank test. Multivariate analyses of the associations between disease-free survival (DFS) and clinical variables including BAP1 protein expression, tumor size, Karnofsky performance status (KPS) score, and the extension level of the tumor thrombus were performed using a Cox proportional hazard model.Results
The median follow-up time was 58.8 months (range: 2–130 months). The median age was 68 years (range: 37–80 years). The median size of the primary tumor was 9.6 cm (range: 3.0–15.0 cm). The IVCTT extended above and below the diaphragm in 10 (28.6%) and 25 (71.4%) patients, respectively. The KPS score was>80 in 23 patients (65.7%). BAP1 protein expression on IHC was positive in 24 cases (68.8%) and negative in 11 cases (31.2%). The median overall survival in cases with BAP1-negative and -positive tumor on IHC staining were 44.7 and 81.5 months, respectively (P = 0.052). BAP1-negative tumor on IHC staining was associated with a significantly shorter DFS than BAP1-positive tumor (median DFS = 10.0 vs. 26.0 months, respectively; P = 0.011). Multivariate analysis showed that only BAP1-negative tumor on IHC staining was significantly associated with shorter DFS (P = 0.004).Conclusions
Patients whose tumors had loss of BAP1 protein expression were significantly associated with poor prognosis in patients with ccRCC with an IVCTT who underwent radical nephrectomy and tumor thrombectomy. 相似文献993.
Kazuhiro Matsumoto Naoya Niwa Seiya Hattori Toshikazu Takeda Shinya Morita Takeo Kosaka Ryuichi Mizuno Toshiaki Shinojima Eiji Kikuchi Hiroshi Asanuma Mototsugu Oya 《Urologic oncology》2018,36(7):341.e9-341.e14
Purpose
Monitoring the serum level of prostate specific antigen (PSA) is indispensable for surveillance after radical therapy, and the aim of this study was to establish the optimal follow-up schedule.Materials and methods
We retrospectively reviewed the clinicopathological data of 1,010 consecutive patients who underwent radical prostatectomy. After excluding patients who received neoadjuvant or adjuvant therapy and those without a nadir PSA level<0.2 ng/ml, the remaining 779 patients were enrolled. Biochemical recurrence (BCR) was defined as elevation of PSA to >0.2 ng/ml. We investigated the PSA doubling time (PSA-DT) following BCR at various times after surgery.Results
During a mean follow-up of 8.8 years, BCR occurred in 180/779 patients. The annual BCR rate was 6% in the first year after surgery, 6% between 1 and 2 years, 3% between 2 and 3 years, 3% between 3 and 5 years, and 2% at >5 years postoperatively. During these periods, the minimum PSA-DT after BCR was 1.6, 2.4, 3.1, 6.1, and 6.4 months, respectively. These minimum PSA-DTs were used to determine the optimal follow-up interval during each period after surgery. If the baseline level is 0.1 ng/ml, PSA should be measured at approximately 3-month intervals for the first year, at 4-month intervals between 1 and 2 years, at 6-month intervals between 2 and 3 years, and annually thereafter to definitely detect BCR before the serum PSA level exceeds 0.4 ng/ml.Conclusion
The PSA-DT following BCR varies according to the time after surgery. Our data on minimum PSA-DT values after BCR are useful for setting the optimal follow-up schedule. 相似文献994.
Noriko Makihara MD Kazunori Toyoda MD Ken Uda MD Tooru Inoue MD Seiji Gotoh MD Shigeru Fujimoto MD Kotaro Yasumori MD Setsuro Ibayashi MD Mitsuo Iida MD Yasushi Okada MD 《Journal of ultrasound in medicine》2008,27(9):1345-1352
Objective. Restenosis of the carotid artery after carotid endarterectomy (CEA) is a major complication. The frequency, time of occurrence, and tissue characteristics of carotid restenosis were assessed with sonography. Methods. Two hundred sixteen patients who had CEA for carotid stenosis were studied; follow‐up sonography and magnetic resonance angiography were done 2 weeks, 3 months, and then every year after CEA. On sonography, restenosis was defined as an internal carotid artery (ICA) with a peak systolic velocity of 170 cm/s or greater or a maximum area of stenosis of 90% or greater. Results. During 605 artery‐years of follow‐up, 18 patients (7.5%) were found to have restenosis on sonography: 4 at 3 months, 11 at 1 year, and 3 at 2 years after CEA. At the time that restenosis was detected, in all 18 ICAs the peak systolic velocity exceeded 200 cm/s and had more than doubled since the last measurement (mean ± SD, 103 ± 27 to 321 ±107 cm/s), whereas the area of stenosis exceeded 90% in 6 patients, and magnetic resonance angiography revealed stenosis of 60% or greater in 8 patients. On sonography, all of the restenotic plaques were isoechoic and concentric. The restenosis was asymptomatic in 17 patients. Vascular risk factors or the severity of initial carotid stenosis before CEA were not associated with development of restenosis. Eleven patients had successful endovascular therapy, and the others received medical treatment. Conclusions. A marked increase in the flow velocity through an operated ICA is a good indication of restenosis. The isoechogenicity and concentricity of the restenotic plaques suggest that the restenosis is primarily the result of intimal hyperplasia. 相似文献
995.
Atsushi Ohazama Eric B. Johnson Masato S. Ota Hong J. Choi Thantrira Porntaveetus Shelly Oommen Nobuyuki Itoh Kazuhiro Eto Amel Gritli-Linde Joachim Herz Paul T. Sharpe 《PLoS Clinical Trials》2008,3(12)
The extent to which cell signaling is integrated outside the cell is not currently appreciated. We show that a member of the low-density receptor-related protein family, Lrp4 modulates and integrates Bmp and canonical Wnt signalling during tooth morphogenesis by binding the secreted Bmp antagonist protein Wise. Mouse mutants of Lrp4 and Wise exhibit identical tooth phenotypes that include supernumerary incisors and molars, and fused molars. We propose that the Lrp4/Wise interaction acts as an extracellular integrator of epithelial-mesenchymal cell signaling. Wise, secreted from mesenchyme cells binds to BMP's and also to Lrp4 that is expressed on epithelial cells. This binding then results in the modulation of Wnt activity in the epithelial cells. Thus in this context Wise acts as an extracellular signaling molecule linking two signaling pathways. We further show that a downstream mediator of this integration is the Shh signaling pathway. 相似文献
996.
Usui S Suzuki K Yamanaka H Nakano T Nakajima K Hara Y Okazaki M 《Clinica chimica acta; international journal of clinical chemistry》2002,317(1-2):133-143
BACKGROUND: Estrogen administration is known to increase serum triglyceride concentrations. This study measured changes in lipoproteins of patients with prostate cancer treated with estrogen to determine whether the increased triglyceride concentrations are associated with atherogenic lipoprotein patterns. METHODS: Fifteen patients (52-87 years) with histologically diagnosed prostate cancer received diethylstilbestrol diphosphate (250 mg/day). Serum samples were collected before and after 1 and 2 weeks of treatment. Cholesterol and triglyceride profiles of major lipoproteins were determined by HPLC, remnant-like particle cholesterol and triglyceride concentrations by an immunoseparation technique, and apolipoproteins by immunologic methods. RESULTS: Estrogen treatment induced a 63.3% increase in total triglyceride concentrations, which occurred in all major lipoprotein classes with significant increases in HDL-triglycerides (130.4%), LDL-triglycerides (60.7%) and VLDL-triglycerides (56.2%). HDL-cholesterol increased significantly by 26.8%, while LDL-cholesterol decreased (15.6%). Remnant-like particle triglyceride concentrations also increased significantly by 77%, whereas remnant-like particle cholesterol concentrations remained unchanged. Apolipoproteins A-I and A-II increased; apolipoprotein E and Lp(a) decreased. CONCLUSIONS: The techniques used here conveniently demonstrated that short-term estrogen treatment in prostate cancer patients resulted in triglyceride enrichment of all major lipoprotein classes but did not induce changes in the lipoprotein profiles generally recognized as increasing risk for cardiovascular disease, except for the elevation of plasma triglyceride and remnant-like particle triglyceride. 相似文献
997.
Satoshi Akamine Yoshito Ishizaki Yasunari Sakai Hiroyuki Torisu Ryoko Fukai Noriko Miyake Kazuhiro Ohkubo Hiroshi Koga Masafumi Sanefuji Ayumi Sakata Masahiko Kimura Seiji Yamaguchi Osamu Sakamoto Toshiro Hara Hirotomo Saitsu Naomichi Matsumoto Shouichi Ohga 《European journal of medical genetics》2018,61(8):451-454
Mutations in the X-linked gene CDKL5 cause early-onset epileptic encephalopathy and severe developmental delay. Because this disorder predominantly affects females, the full clinical spectrum of male patients remains elusive. We herein report a 16-year-old boy, who suffered from intractable seizures 20 days after birth. Serial electroencephalograms detected recurrent focal epileptiform discharges from age 4 months, which evolved to hypsarrhythmia later in infancy. Mass-spectrometric analyses revealed increase in urinary excretion of methylmalonic acid without perturbed concentrations of propionic acid, homocystein and methionine. Whole-exome sequencing identified a de novo, truncating mutation in CDKL5 (NM_003159.2:c.419dupA, p.Asn140Lysfs*8). Targeted sequencing excluded concomitant mutations in methylmalonic academia-associated genes. No methylmalonic acidemia has been reported in children with CDKL5 disorder. Extensive analyses on organic acid metabolism for males with CDKL5 mutations will gain more insight into their biochemical profiles in infancy. 相似文献
998.
Tomohito Nagaoka Yuji Seki Kazuhiro Uzawa Mai Takigami Daniel Morales Chocano 《Anatomical science international / Japanese Association of Anatomists》2018,93(2):254-261
Cribra orbitalia is characterized by an aggregation of small apertures in the orbital roof in response to marrow hypertrophy. This pathological change is indicative of biological stress during youth. We examined the prevalence of this lesion in Pacopampa, a ceremonial center of the formative period, located in the northern highlands of Peru. Using this evaluation of cribra orbitalia, we reconstructed aspects of the population’s health and nutritional status during the formation of Andean civilization. We examined 41 orbits of 27 adult individuals (13 males, 14 females) and recorded the macroscopic presence or absence of cribra orbitalia. The presence or absence of cribra orbitalia was the same bilaterally for all 14 individuals having both orbits preserved. The pathology was present in two of the 13 males (15.4%), one of the 14 (7.1%) females, and three of 27 individuals (11.1%) for both sexes combined. There was no difference in the frequency between sexes. The prevalence of cribra orbitalia was found to be lower in Pacopampa than in the comparative data of coastal populations. It is reasonable to assume that the increase in social complexity in Pacopampa was probably unrelated to the decline in overall health of the people. 相似文献
999.
1000.